BMN165
Showing 1 - 8 of 8
Phenylketonuria (PKU) Trial in United States (BMN165 20mg/day, BMN165 40mg/day, Placebo)
Completed
- Phenylketonuria (PKU)
- BMN165 20mg/day
- +2 more
-
La Jolla, California
- +28 more
Apr 29, 2021
A Phase 3 Substudy to Evaluate Executive Function in PKU Who Are
Completed
- Phenylketonuria
- Administration of CANTAB and Subject Global Assessment
-
Lexington, Kentucky
- +3 more
May 21, 2020
Phenylketonuria Trial in United States (rAvPAL-PEG 0.001 mg/kg, rAvPAL-PEG 0.003 mg/kg, rAvPAL-PEG 0.01 mg/kg)
Completed
- Phenylketonuria
- rAvPAL-PEG 0.001 mg/kg
- +4 more
-
Aurora, Colorado
- +10 more
Feb 4, 2019